Inventor · disambiguated record
Chang-Hai Tsai
Also filed as: TSAI Chang-Hai
11 granted patents·8 pending applications·6 citations·filing 2015–2025
82Inventor score
Top patents by PatentIndex Score
19 records- 0189US10988733B2Methods for obtaining pluripotent adult olfactory stem cells from an olfactory mucosa tissueUNIV CHINA MEDICAL·Filed 2020·Granted Apr 27, 2021·2 cites·3 claims
- 0283US10660918B2Method for enhancing insulin like growth factor 1 receptor expression of mesenchymal stem cell, method for isolating mesenchymal stem cell, and use of mesenchymal stem cellUNIV CHINA MEDICAL·Filed 2017·Granted May 26, 2020·1 cites·6 claims
- 0382US12226437B2Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell expressing IGF1R and method for obtaining multipotent umbilical cord mesenchymal stem cellUNIV CHINA MEDICAL·Filed 2022·Granted Feb 18, 2025·0 cites·4 claims
- 0479US10736964B2Immunomagnetic nanocapsule and kit for treating cancerUNIV CHINA MEDICAL·Filed 2018·Granted Aug 11, 2020·1 cites·11 claims
- 0576US10787413B2Derivatives of curcuminoids and use thereof as an anticancer agentUNIV CHINA MEDICAL·Filed 2017·Granted Sep 29, 2020·1 cites·20 claims
- 0676US10696945B2Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem cellsUNIV CHINA MEDICAL·Filed 2017·Granted Jun 30, 2020·1 cites·2 claims
- 0772US2025152634A1Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell and method for obtaining multipotent umbilical cord mesenchymal stem cellUNIV CHINA MEDICAL·Filed 2025·Application pending·0 cites
- 0871US11529373B2Method for enhancing expression of insulin like growth factor 1 receptor in mesenchymal stem cell, method for obtaining mesenchymal stem cell, and method for treating brain tissue damageUNIV CHINA MEDICAL·Filed 2020·Granted Dec 20, 2022·0 cites·4 claims
- 0961US2017020924A1Mesenchymal stem cell, method for clonogenic expansion thereof, method for isolating thereof, and use thereofUNIV CHINA MEDICAL·Filed 2015·Application pending·0 cites
- 1055US11458171B2Engineering stem cells for cancer therapyUNIV CHINA MEDICAL·Filed 2019·Granted Oct 4, 2022·0 cites·16 claims
- 1154US11110129B2Method for treating multiple sclerosisUNIV CHINA MEDICAL·Filed 2019·Granted Sep 7, 2021·0 cites·5 claims
- 1252US2021386695A1Use Of Disulfiram For Treating Infection Of SARS-COV-2UNIV CHINA MEDICAL·Filed 2021·Application pending·0 cites
- 1351US11760980B2Induced pluripotent stem cells (IPSCS) and applications thereofUNIV CHINA MEDICAL·Filed 2019·Granted Sep 19, 2023·0 cites·5 claims
- 1451US2024261279A1Method for treating lung cancerHUNG MIEN CHIE·Filed 2022·Application pending·0 cites
- 1550US2023220350A1Gene-engineered mesenchymal stem cells and applications thereofUNIV CHINA MEDICAL·Filed 2020·Application pending·0 cites
- 1648US2023338434A1Method for treating ischemia condition of tissueSHYU WOEI CHERNG·Filed 2021·Application pending·0 cites
- 1746US2024000742A1Method for treating lung cancerHUNG MIEN CHIE·Filed 2021·Application pending·0 cites
- 1844US2020323966A1Combination therapies comprising dendritic cells-based vaccine and immune checkpoint inhibitorUNIV CHINA MEDICAL·Filed 2019·Application pending·0 cites
- 1936US10035791B2Bicyclic compound and pharmaceutical composition thereof for treating stroke and use thereofUNIV CHINA MEDICAL·Filed 2016·Granted Jul 31, 2018·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Chang-Hai Tsai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →